Mathew Hulett - PetMed Express President CEO
| PETS Stock | USD 4.58 0.05 1.10% |
CEO
Mathew Hulett is President CEO of PetMed Express
| Age | 53 |
| Address | 420 South Congress Avenue, Delray Beach, FL, United States, 33445 |
| Phone | 561 526 4444 |
| Web | https://www.1800petmeds.com |
Mathew Hulett Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mathew Hulett against PetMed Express stock is an integral part of due diligence when investing in PetMed Express. Mathew Hulett insider activity provides valuable insight into whether PetMed Express is net buyers or sellers over its current business cycle. Note, PetMed Express insiders must abide by specific rules, including filing SEC forms every time they buy or sell PetMed Express'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mathew Hulett over six months ago Disposition of 510000 shares by Mathew Hulett of PetMed Express subject to Rule 16b-3 |
PetMed Express Management Efficiency
Return On Tangible Assets is likely to gain to -0.05 in 2024. Return On Capital Employed is likely to gain to -0.08 in 2024. At this time, PetMed Express' Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 5.5 M in 2024, whereas Total Current Assets are likely to drop slightly above 79 M in 2024. PetMed Express' management efficiency ratios could be used to measure how well PetMed Express manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | CEO Age | ||
| Yoko Miyashita | Leafly Holdings | 48 | |
| Timothy Wentworth | Walgreens Boots Alliance | 64 | |
Management Performance
| Return On Equity | -0.0092 | |||
| Return On Asset | -9.0E-4 |
PetMed Express Leadership Team
Elected by the shareholders, the PetMed Express' board of directors comprises two types of representatives: PetMed Express inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PetMed. The board's role is to monitor PetMed Express' management team and ensure that shareholders' interests are well served. PetMed Express' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PetMed Express' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Moseley, Chief Officer | ||
| Carla Dodds, Chief Officer | ||
| Sandra Campos, CEO President | ||
| Matthew Hulett, Pres CEO | ||
| Umesh Sripad, Chief Officer | ||
| Christine Chambers, Treasurer Secretary | ||
| Mathew Hulett, President CEO | ||
| Daniel Pingree, Chief Officer | ||
| Doug Krulik, Chief Officer | ||
| Caroline Conegliano, Chief Officer | ||
| Jacqueline Smith, Vice People | ||
| Bruce Rosenbloom, CFO, Principal Accounting Officer and Treasurer | ||
| Wendy Zalai, Corporate Secretary | ||
| Robyn DElia, Chief Officer |
PetMed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PetMed Express a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0092 | |||
| Return On Asset | -9.0E-4 | |||
| Profit Margin | (0) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 43.82 M | |||
| Shares Outstanding | 20.66 M | |||
| Shares Owned By Insiders | 8.10 % | |||
| Shares Owned By Institutions | 47.86 % | |||
| Number Of Shares Shorted | 1.7 M | |||
| Price To Earning | 12.75 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PetMed Stock Analysis
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.